Wysocki-Led Facility Recognized for Proteomics, Disease Research
and Mass Spectrometry Excellence
MILFORD, Mass.--(BUSINESS WIRE)--Sep. 22, 2015--
At a ceremony at The Ohio State University, Waters Corporation
(NYSE:WAT) officially welcomed the University’s Campus
Chemical Instrument Center into the Waters
Centers of Innovation Program. Headed
by Prof.
Vicki Wysocki, an Ohio Eminent Scholar and Professor of Chemistry
and Biochemistry, the Center is widely renowned for fundamental research
into ways of characterizing protein complexes, or assemblies of multiple
individual proteins, that living organisms depend on for their survival.
Ultimately, the research of the Wysocki
Research Group could one day lead to new understanding of
conditions, such as high blood pressure, arteriosclerosis,
pre-eclampsia, and chronic obstructive pulmonary disease, among others.
“We are honored to join the Waters Centers of Innovation Program as a
partner and applaud the state-of-the-art instrumentation and technical
support that Waters has provided,” said Caroline Whitacre, Vice
President for Research at Ohio State. “Having access to the Waters
technology has enabled the stellar work of Dr. Wysocki as she works to
develop improved mass spectrometry approaches to determine structures of
protein complexes. This research is helping researchers across the Ohio
State campus and elsewhere to achieve breakthroughs and develop
solutions that will have global impact.”
Also on hand to congratulate Prof. Wysocki and her team was Eric
Fotheringham, Director, Waters Centers of Innovation Program. “Vicki is
an exemplary scientist and a highly-respected member of the worldwide
mass spectrometry community. She is certainly deserving of this
recognition and we are proud to have her participate in our program.”
Abetting Wysocki in her research are advances in mass spectrometry
technologies that allow her to probe the structures of protein complexes
like never before.
“One of the important goals of our research is understanding how we
might interrupt a disease or correct for a disease, or develop a drug
target. Waters instruments are important to our research because of the
ion mobility technology embedded in their quadrupole time-of-flight mass
spectrometers. This technology allows us to measure not just a protein
complex’s mass/charge ratio but also their shape, and this is incredibly
important if we are to understand their function or identify when
unfolding has occurred, which can be a sign of damage caused by an
adverse event,” said Wysocki.
The driving force behind the technique of surface induced dissociation
(SID) for mass spectrometry, Prof. Wysocki leads a research group
exploring new ways of examining protein complexes by experimenting with
SID on various instrument platforms. A mother, a teacher and a mentor,
Prof. Wysocki is also an officer with the American Society for Mass
Spectrometry (ASMS), currently serving as Vice-President for Programs.
In 1992, Professor Wysocki received an ASMS
Research Award, presented annually to young academic scientists to
further her research in mass spectrometry, and in 2009 she received a
Distinguished Contribution to Mass Spectrometry Award, the Society’s
highest achievement award. She is also one of 120 distinguished
scientists, and one of six women, profiled in Elsevier’s
Encyclopedia of Mass Spectrometry (2015) for contributions to mass
spectrometry over the last century.
In recognition of Prof. Wysocki, Waters is sponsoring a symposium on
Tuesday, September 22 titled Mass Spectrometry in Structural Biology on
the campus of The Ohio State University. Giving invited lectures at the
Symposium are Prof. David Russell, Texas A&M Prof. Joseph Loo, UCLA;
Prof. Evan Williams, UC Berkeley; Prof. Lisa Jones, IUPUI; Prof. Perdita
Barran, University of Manchester (UK); Prof. David Clemmer, Indiana
University; and Kevin Giles, Waters Corporation.
About The Ohio State University
The Ohio State University is a dynamic community of diverse resources,
where opportunity thrives and where individuals transform themselves and
the world. Founded in 1870, Ohio State is a world-class public research
university and the leading comprehensive teaching and research
institution in the state of Ohio. With more than 64,000 students
(including 58,000 in Columbus), the Wexner Medical Center, 15 colleges,
80 centers and more than 200 majors, the university offers its students
tremendous breadth and depth of opportunity in the liberal arts, the
sciences and the professions.
About Waters Centers of Innovation Program
Waters
Centers of Innovation Program recognizes and supports the efforts of
scientists, facilitating breakthroughs in health and life science
research, food safety and food science, environmental protection, sports
medicine and many other areas. Waters provides scientists and their
institutions in the Program with early access to pre-commercialized
novel technology that may lead to scientific breakthroughs and
jump-start a research project. In other instances, collaborative efforts
between Waters expert applications scientists and Program participants
have accelerated research in important ways.
In addition to Professor Wysocki, other researchers and research centers
recognized by the Waters Centers of Innovation Program include: Professor
Ganesh Anand, National University of Singapore; Professor
Luiz Claudio Cameron, UniRio, Brazil; Professor
David Clemmer, Indiana University; Professor
Daniel Tsun-Yee Chiu, Chang Gung University; Dr.
Joseph Dalluge, University of Minnesota; Dr. Petur Weihe Dalsgaard, University
of Copenhagen; Professor
Marcos Eberlin, University of Campinas, Brazil; Prof.
Chris Elliott, Queen’s University Belfast; Professor
John Engen, Northeastern University; Professor
Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer
Center; Professor
David Goodlett and Dr.
Maureen Kane, University of Maryland; Professor De-an Guo, Shanghai
Institute of Materia Medica; Dr.
Frank Gonzalez, National Cancer Institute; Dr. Carlo R. Largiadèr,
Dr. Jean-Francois DuFour and Dr. Martin Fiedler, Inselspital
University Hospital; Professor
Julie Leary, University of California – Davis; Professor
Amit Kumar Mandal, St. John’s Research Institute, Bangalore, India; Professor
John McLean, Vanderbilt University; Professor
Arthur Moseley, Duke University; Professor
Jeremy Nicholson, Imperial College London; Dr.
Devin Peterson, University of Minnesota; Assistant
Professor
Jessica Prenni, Colorado State University; Dr. Serge Rezzi, Nestle
Institute of Health Sciences; Dr.
Ryan Rodgers, Future Fuels Institute, Florida State University; Professor
Pauline Rudd, National Institute for Bioprocessing Research and
Training; Professor
James Scrivens, University of Warwick; Professor
Vladimir Shulaev, University of North Texas; Dr.
Norman Smith, Kings College London; Professor
Sarah Trimpin, Wayne State University; Professor
Bert van Bavel, Örebro University; Caroline West and Eric Lesselier, University
of Orleans, Orleans, France;.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation (NYSE:WAT) has created
business advantages for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant advancements
in such areas as healthcare delivery, environmental management, food
safety, water quality, consumer products, and high value-added chemicals
worldwide.
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring
platform for customer success.
With revenue of $1.99 billion in 2014, Waters is driving scientific
discovery and operational excellence for customers worldwide.
# # #
Waters and Synapt are trademarks of Waters Corporation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150922005518/en/
Source: Waters Corporation
Waters Corporation
Brian J. Murphy, +1 508-482-2614
Public
Relations
brian_j_murphy@waters.com